SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001720725-21-000077
Filing Date
2021-08-05
Accepted
2021-08-05 16:48:56
Documents
6
Effectiveness Date
2021-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 oysterpoint-formsx82021ind.htm S-8 98994
2 EX-5 oysterpoint-2021formsx8ind.htm EX-5 8182
3 EX-23 a231-pwcconsent.htm EX-23 1985
4 image_4.jpg GRAPHIC 8359
5 image_5.jpg GRAPHIC 173
6 image_6.jpg GRAPHIC 21783
  Complete submission text file 0001720725-21-000077.txt   152019
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258498 | Film No.: 211149108
SIC: 2836 Biological Products, (No Diagnostic Substances)